BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20540350)

  • 1. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
    Lagarde M; Ghazi I; Dechavanne M
    Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 6. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB; Dodge JA
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 9. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
    Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
    Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The platelet fibrinogen receptor.
    Peerschke EI
    Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
    [No Abstract]   [Full Text] [Related]  

  • 15. Formation by phospholipase A2 of prostaglandins and endoperoxides in platelets of normal and essential fatty acid-deficient rats.
    Vincent JE; Zijlstra FJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():143-6. PubMed ID: 655005
    [No Abstract]   [Full Text] [Related]  

  • 16. Endogenous antiaggregatory prostaglandins can contribute to inhibition of hemostasis: a pharmacological study in vivo in humans.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():248-53. PubMed ID: 2821758
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandins, thromboxanes and platelets.
    Malmsten C
    Br J Haematol; 1979 Apr; 41(4):453-8. PubMed ID: 219881
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of prostaglandins in platelet function.
    Burch JW; Majerus PW
    Semin Hematol; 1979 Jul; 16(3):196-207. PubMed ID: 113883
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of methyl mercury on platelets: induction of aggregation and release via activation of the prostaglandin synthesis pathway.
    Macfarlane DE
    Mol Pharmacol; 1981 May; 19(3):470-6. PubMed ID: 7266471
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.